Gamma/Delta T-cell Receptor Type Granular Lymphocyte Proliferative Disorder Associated with Rheumatoid Arthritis

Author： Zenibayashi M Saigo K Chayahara N Sakamoto Y Inujima K Imamura Y Takada M Kawano S Tatsumi E Kumagai S

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.33, Iss.5, 2005-09, pp. : 583-589

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulation of T-Cell Co-Stimulation in Rheumatoid Arthritis: Clinical Experience with Abatacept

By Laganà Bruno Vinciguerra Marta D'Amelio Raffaele

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 185-202

Adis International

Access to resources Recommend Favorite

T cell immunoglobulin-3 as a new therapeutic target for rheumatoid arthritis

By Li Xia Zhao Yi-Qing Li Cheng-Wan Yuan Feng-Lai

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 12, 2012-12 ,pp. : 1145-1149

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin II type 1 receptor antagonists such as losartan may have potential in the treatment of rheumatoid arthritis

Inpharma, Vol. 1, Iss. 1581, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Premature Cell Senescence and T Cell Receptor–Independent Activation of CD8+ T Cells in Juvenile Idiopathic Arthritis

Arthritis & Rheumatism, Vol. 65, Iss. 8, 2013-08 ,pp. : 2201-2210

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative study of lymphocyte-suppressive potency between prednisolone and methylprednisolone in rheumatoid arthritis

By Hirano T. Tsuboi N. Homma M. Oka K. Takekoshi T. Tahara K. Takanashi H. Abe H. Urata Y. Hayashi T.

Immunopharmacology, Vol. 49, Iss. 3, 2000-09 ,pp. : 411-417

Elsevier

Access to resources Recommend Favorite